Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: Early identification of autism spectrum disorder (ASD) is essential for improving developmental outcomes but remains challenging due to diagnostic delays, subjectivity, and resource limitations. Eye-tracking offers objective indices of social attention and could improve access to early screening when deployed on consumer devices at home. This scoping review synthesizes evidence on home...
Early detection and biological characterization of Alzheimer's disease (AD) remain challenging, as current diagnostic approaches rely on invasive cerebrospinal fluid (CSF) sampling or costly neuroimaging, limiting scalability. Sleep quantitative electroencephalography (qEEG) provides a non-invasive measure of brain function and may capture early AD-related neural alterations; however, the high dim...
Semi-quantitative positron emission tomography (PET) analysis, particularly Centiloid and CenTauRz scaling, is essential for Alzheimer's disease (AD) ...
Artificial Intelligence (AI) has become integral to the research of neurological diseases due to the rapid expansion of neuroimaging, clinical, physio...
BACKGROUND: Stanozolol, a synthetic anabolic androgenic steroid (AAS) widely abused to enhance performance, has poorly defined toxicological mechanism...
BACKGROUND: Dementia caregiving entails chronic, fluctuating stress with downstream risks to caregivers' mental health and quality of care. Mindfulnes...
OBJECTIVE: This study uses bibliometric analysis and knowledge mapping methods to systematically explore the emerging research frontiers and developme...
As a progressive neurodegenerative disorder, Alzheimer's disease (AD) requires early and accurate diagnosis to delay pathological progression and impr...
Targeting the intrinsically disordered N-terminal domain of the androgen receptor (AR-NTD) represents a promising strategy to overcome resistance in p...
Neurodegenerative diseases, such as Mild Cognitive Impairment (MCI) and Alzheimer's, pose significant challenges due to their progressive nature and l...
BACKGROUND: Atherosclerosis is a major cause of ischemic stroke and is characterized by complex immune-metabolic dysregulation. VAV3, a Rho guanine nu...
BACKGROUND: In an attempt to overcome the space-time limitations of traditional training we used a new telemedicine home-training model (Videotraining...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are described as a disease continuum, given their shared clinical, genetic and p...
The use of amyloid PET to assess patient suitability of disease-modifying drugs for Alzheimer disease is increasing. This study aimed to synthesize am...
BackgroundAlzheimer's disease (AD) lacks effective disease-modifying therapies and scalable, ecologically valid biomarkers to monitor treatment respon...
BackgroundAlzheimer's disease (AD) is the most common cause of dementia whose prevalence is projected to increase significantly in the coming decades....
BackgroundNeuropsychiatric symptoms (NPS) are common in Alzheimer's disease (AD) and mild cognitive impairment (MCI), yet their detection relies on su...
Accurate quantification of structurally similar metabolites as biomarkers in biofluids has remained a longstanding challenge. Here, we report a semico...
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by complex molecular alterations across multiple brain regions. ...
OBJECTIVE: High accuracy in medical classification tasks does not ensure that neural networks reason in ways consistent with clinical or neurobiologic...